Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Elizabeth Ojewole"'
Autor:
Kelechi Elizabeth Oladimeji, Joyce Mahlako Tsoka-Gwegweni, Elizabeth Ojewole, Samuel Tassi Yunga
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-12 (2019)
Abstract Background Adequate knowledge of malaria prevention and control can help in reducing the growing burden of malaria among vulnerable groups, particularly pregnant women and children aged under 5 years living in malaria endemic settings. Simil
Externí odkaz:
https://doaj.org/article/0dfc40ed19954081bd5537e59609bf7f
Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol
Publikováno v:
Systematic Reviews, Vol 7, Iss 1, Pp 1-6 (2018)
Abstract Background According to the United Nations Trends in Contraceptive Use 2015 report, at least one in ten married or in-union women in most regions of the world has an unmet need for family planning. Family Planning 2020 reports an estimate of
Externí odkaz:
https://doaj.org/article/ca98eeda1a2142ca9a9e1e330ec36499
Publikováno v:
Evidence-based Complementary and Alternative Medicine : eCAM
Evidence-Based Complementary and Alternative Medicine, Vol 2022 (2022)
Evidence-Based Complementary and Alternative Medicine, Vol 2022 (2022)
Background. Informed consent (IC) is constitutionally protected in South Africa based on individual rights to bodily integrity and well-being. In terms of the law, patients cannot be involved in medical treatment or research without IC. This study ex
Autor:
Elisa López Varela, Elizabeth Ojewole, Tasmiya Raúfo Irá, Neusa Torres Tovela, Richard Beharilal, Pravina Devi Laljeeth
Background: Adverse drug reactions (ADRs) remain a significant public health concern worldwide mainly in developing countries. Adverse drug reactions due to multi-drugs regimen for the treatment of tuberculosis (TB) have negative implications such as
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::51831cf0673b066c66496aae9676dbcd
https://doi.org/10.21203/rs.3.rs-678037/v1
https://doi.org/10.21203/rs.3.rs-678037/v1
Autor:
Joyce Mahlako Tsoka-Gwegweni, Samuel Tassi Yunga, Kelechi Elizabeth Oladimeji, Elizabeth Ojewole
Publikováno v:
Malaria Journal, Vol 18, Iss 1, Pp 1-12 (2019)
Malaria Journal
Malaria Journal
Background Adequate knowledge of malaria prevention and control can help in reducing the growing burden of malaria among vulnerable groups, particularly pregnant women and children aged under 5 years living in malaria endemic settings. Similar studie
Publikováno v:
PLoS ONE, Vol 16, Iss 11 (2021)
PLoS ONE, Vol 16, Iss 11, p e0259402 (2021)
PLoS ONE
PLoS ONE, Vol 16, Iss 11, p e0259402 (2021)
PLoS ONE
BackgroundFoods and the nutrients they contain can interact with drugs and thereby interfere with their therapeutic safety and efficacy. Adequate knowledge of healthcare professionals (HCPs) about drug-food interactions can help in preventing potenti
Evidence of patients’ challenges and barriers related to usage of Implanon®: scoping review protocol
Publikováno v:
Systematic Reviews, Vol 7, Iss 1, Pp 1-6 (2018)
Systematic Reviews
Systematic Reviews
Background According to the United Nations Trends in Contraceptive Use 2015 report, at least one in ten married or in-union women in most regions of the world has an unmet need for family planning. Family Planning 2020 reports an estimate of almost 1
Publikováno v:
The International journal of pharmacy practice. 29(5)
Objectives Drug–food interactions (DFIs) are a problem in clinical practice as they can alter the bioavailability of drugs and nutrients and may lead to various adverse effects. Healthcare professionals (HCPs) play a significant role in counselling
Publikováno v:
Drug Development and Industrial Pharmacy. 40:657-668
The aim of this study was to explore the potential of novel oleic acid (OA) derivatives as buccal permeation enhancers for the delivery of didanosine (ddI). The OA derivatives, i.e. ester derivative (OA1E), the dicarboxylic acid derivative (OA1A) and
Publikováno v:
African journal of AIDS research : AJAR. 15(3)
South Africa has one of the highest prevalences of HIV and AIDS in the world. HIV/AIDS patients face countless challenges, one of which is the risk of adverse drug reactions (ADRs). This study aimed to describe the ADRs reported in South Africa with